Showing 21 - 40 results of 872 for search '"preclinical"', query time: 0.07s Refine Results
  1. 21

    Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening by Lisa Götz, Jenny Wegert, Alireza Paikari, Silke Appenzeller, Sabrina Bausenwein, Christian Vokuhl, Taryn D. Treger, Jarno Drost, Christin Linderkamp, Dominik T. Schneider, Karen Ernestus, Steven W. Warman, Jörg Fuchs, Nils Welter, Norbert Graf, Sam Behjati, Rhoikos Furtwängler, Manfred Gessler

    Published 2025-02-01
    “…Adherent, spheroid and organoid cultures are also clearly distinguishable by their transcriptome. Preclinical drug screening experiments revealed sensitivity to a range of inhibitors, that are highly effective in other childhood solid tumors. …”
    Get full text
    Article
  2. 22

    Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma by Nan Li, Haiying Qin, Rosa Nguyen, Mitchell Ho, Ming Sun, Eytan Ruppin, Michael C Kelly, Yingying Cao, Reona Okada, Jeyshka M Reyes-González, Hannah G Stack, Charlie Seibert, Carol J Thiele

    Published 2023-01-01
    “…We developed a new chimeric antigen receptor (CAR) targeting glypican-2 (GPC2) and conducted iterative preclinical engineering of the CAR structure to maximize its anti-tumor efficacy before clinical translation.Methods We evaluated different GPC2-CAR constructs by measuring the CAR activity in vitro. …”
    Get full text
    Article
  3. 23
  4. 24

    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol. by Yuan Tian, Maneesh V Kuruvilla, Mira Park

    Published 2023-01-01
    “…<h4>Introduction</h4>Preclinical Alzheimer's disease (AD) represents the earliest phase of AD, often years before the onset of mild cognitive impairment (MCI). …”
    Get full text
    Article
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies by Li-Chun Lu, Gen-Sheng Feng, Chih-Hung Hsu

    Published 2023-04-01
    “…Data Sources and Study Selection: We enrolled relevant clinical and preclinical studies conducted by our groups and others. …”
    Get full text
    Article
  11. 31

    Self-Assessment of Medical Ethics and Professionalism: Comparison Between Preclinical and Clinical Medical Students by Saima Naz Shaikh, Uzair Abbas, Tazeen Shah, Arsalan Ahmad Uqaili, Hudebia Allah Buksh, Mehreen Fatima

    Published 2025-01-01
    “…This study aims to compare knowledge and self-reported practice of ethics and professionalism between preclinical and clinical undergraduate medical students. …”
    Get full text
    Article
  12. 32

    Oxygenation and function of endocrine bioartificial pancreatic tissue constructs under flow for preclinical optimization by Brenden N Moeun, Florent Lemaire, Alexandra M Smink, Hamid Ebrahimi Orimi, Richard L Leask, Paul de Vos, Corinne A Hoesli

    Published 2025-01-01
    “…This system can complement other preclinical platforms to de-risk and optimize BAPs and other artificial tissue designs prior to clinical studies.…”
    Get full text
    Article
  13. 33

    A meta-analysis of the effect of protein synthesis inhibitors on rodent fear conditioning by Carneiro, Clarissa F. D., Amorim, Felippe E., Amaral, Olavo B.

    Published 2023-11-01
    Subjects: “…fear conditioning; preclinical meta-analysis; reproducibility;…”
    Get full text
    Article
  14. 34
  15. 35

    Preclinical Positron Emission Tomographic Imaging of Acute Hyperoxia Therapy of Chronic Hypoxia during Pregnancy by Alexander Zheleznyak, Joel R. Garbow, Michal Neeman, Suzanne E. Lapi

    Published 2015-07-01
    “…Herein we report first-in-mouse PET imaging of fetuses employing both tracers [ 18 F]FDG (metabolism) and 64 Cu-ATSM (hypoxia). [ 18 F]FDG PET/CT imaging allowed clear visualization of placental-fetal structures and supported quantification of tracer uptake, making this a sensitive tool for monitoring placental function in preclinical rodent models. These measurements illustrate the potentially irreversible damage generated by chronic exposure to hypoxia, which cannot be corrected by acute exposure to hyperoxia.…”
    Get full text
    Article
  16. 36
  17. 37

    Stem Cells for Cartilage Repair: Preclinical Studies and Insights in Translational Animal Models and Outcome Measures by Melissa Lo Monaco, Greet Merckx, Jessica Ratajczak, Pascal Gervois, Petra Hilkens, Peter Clegg, Annelies Bronckaers, Jean-Michel Vandeweerd, Ivo Lambrichts

    Published 2018-01-01
    “…But before novel cell-based therapies for cartilage repair can be introduced into the clinic, rigorous testing in preclinical animal models is required. Preclinical models used in regenerative cartilage studies include murine, lapine, caprine, ovine, porcine, canine, and equine models, each associated with its specific advantages and limitations. …”
    Get full text
    Article
  18. 38
  19. 39

    Maximising translational value of the Iowa gambling task in preclinical studies through the use of the rodent touchscreen by Judith A. Pratt, Brian J. Morris

    Published 2025-01-01
    “…The rodent touchscreen apparatus maximises the degree of similarity with the human task, and in this review we provide an outline of the use of rodent touchscreen gambling tasks in preclinical studies of psychiatric conditions. In particular, we describe how the basic task has been adapted to probe the relative contributions of different neurotransmitter systems, and specific aspects of cognition. …”
    Get full text
    Article
  20. 40

    Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma by Hui-Ju Hsieh, Ryan Urak, Mary C. Clark, Larry W. Kwak, Stephen J. Forman, Xiuli Wang

    Published 2025-03-01
    “…Previously, we have shown that AKT Inhibitor VIII, a selective AKT-1/2 inhibitor, during chimeric antigen receptor (CAR) T cell manufacturing, improves CAR T cell function in preclinical models. Although AKT Inhibitor VIII could enhance CAR T cell function, AKT Inhibitor VIII is not a clinical-grade compound. …”
    Get full text
    Article